Patient input is critical to the success of celiac disease clinical trials. Our Patient Advisory Panels, powered by the iQualifyCeliac™ platform and supported by the iCureCeliac® registry, provide sponsors and CROs with authentic, actionable insights from patients who live with celiac disease every day.
By integrating patient perspectives early in protocol development, you reduce barriers to enrollment, improve retention, and design studies that reflect the real-world needs of the celiac community.
Too often, clinical trial protocols are developed without input from the very people who will participate. This can lead to unnecessary burdens, lower enrollment, and higher dropout rates. Patient Advisory Panels (sometimes known as Boards) solve this problem by providing structured, expert-facilitated feedback from verified celiac patients before and during your study.
Unlike generic patient focus groups, our panels are built exclusively for celiac disease studies and backed by decades of advocacy, scientific expertise, and trusted patient relationships worldwide. By combining lived experience with research insight, we help you design studies that panelists want to join and stay in.
Panelist voices are essential to successful celiac disease drug development. With Patient Advisory Panels, you gain real-world insights that make your study more inclusive, feasible, and efficient—while strengthening trust with the celiac community.